Our human and mouse in vivo and in vitro studies indicate that the unspecific immunotherapy of pancreatic carcinoma with IFN can induce not only the activation of anti-tumor immunity, but also the immunosuppression. Here, IFNA1 is linked to exocrine pancreatic carcinoma.